A
Price
$146.42
Change
-$0.99 (-0.67%)
Updated
Mar 28, 10:09 AM EST
54 days until earnings call
BIO
Price
$350.06
Change
+$9.70 (+2.85%)
Updated
Mar 27, 6:59 PM EST
28 days until earnings call
Ad is loading...

Compare trend and price A vs BIO

Header iconA vs BIO Comparison
Open Charts A vs BIOBanner chart's image
Agilent Technologies
Price$146.42
Change-$0.99 (-0.67%)
Volume$818
CapitalizationN/A
Bio-Rad Laboratories
Price$350.06
Change+$9.70 (+2.85%)
Volume$26.9K
CapitalizationN/A
View a ticker or compare two or three
A vs BIO Comparison Chart

Loading...

ADaily Signal changed days agoGain/Loss if shorted
 
Show more...
BIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
A vs. BIO commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and BIO is a StrongBuy.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (A: $147.37 vs. BIO: $349.56)
Brand notoriety: A and BIO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 73% vs. BIO: 93%
Market capitalization -- A: $43.19B vs. BIO: $9.88B
A [@Medical Specialties] is valued at $43.19B. BIO’s [@Medical Specialties] market capitalization is $9.88B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 3 FA rating(s) are green whileBIO’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 3 green, 2 red.
  • BIO’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than BIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while BIO’s TA Score has 4 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 5 bearish.
  • BIO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both A and BIO are a good buy in the short-term.

Price Growth

A (@Medical Specialties) experienced а +0.06% price change this week, while BIO (@Medical Specialties) price change was +3.95% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.03%. For the same industry, the average monthly price growth was -0.11%, and the average quarterly price growth was +4.56%.

Reported Earning Dates

A is expected to report earnings on May 21, 2024.

BIO is expected to report earnings on Apr 25, 2024.

Industries' Descriptions

@Medical Specialties (+1.03% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for A with price predictions.
OPEN
A.I.dvisor published
a Summary for BIO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
A($43.2B) has a higher market cap than BIO($9.88B). A has higher P/E ratio than BIO: A (35.26) vs BIO (3.64). BIO YTD gains are higher at: 8.260 vs. A (5.999). A has higher annual earnings (EBITDA): 1.69B vs. BIO (-654.76M). A has more cash in the bank: 1.75B vs. BIO (1.61B). BIO has less debt than A: BIO (1.41B) vs A (2.56B). A has higher revenues than BIO: A (6.74B) vs BIO (2.67B).
ABIOA / BIO
Capitalization43.2B9.88B437%
EBITDA1.69B-654.76M-258%
Gain YTD5.9998.26073%
P/E Ratio35.263.64968%
Revenue6.74B2.67B252%
Total Cash1.75B1.61B109%
Total Debt2.56B1.41B182%
FUNDAMENTALS RATINGS
A vs BIO: Fundamental Ratings
A
BIO
OUTLOOK RATING
1..100
7967
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
3288
SMR RATING
1..100
4792
PRICE GROWTH RATING
1..100
2357
P/E GROWTH RATING
1..100
4585
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (22) in the Biotechnology industry is somewhat better than the same rating for BIO (78) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than BIO’s over the last 12 months.

A's Profit vs Risk Rating (32) in the Biotechnology industry is somewhat better than the same rating for BIO (88) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than BIO’s over the last 12 months.

A's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for BIO (92) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than BIO’s over the last 12 months.

A's Price Growth Rating (23) in the Biotechnology industry is somewhat better than the same rating for BIO (57) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than BIO’s over the last 12 months.

A's P/E Growth Rating (45) in the Biotechnology industry is somewhat better than the same rating for BIO (85) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than BIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABIO
RSI
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
61%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
58%
Momentum
ODDS (%)
Bearish Trend 1 day ago
51%
Bullish Trend 1 day ago
69%
MACD
ODDS (%)
Bearish Trend 1 day ago
53%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 16 days ago
63%
Bullish Trend 11 days ago
65%
Declines
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
72%
Aroon
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Ad is loading...
ADaily Signal changed days agoGain/Loss if shorted
 
Show more...
BIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIVN55.851.46
+2.68%
LivaNova PLC
PRTG0.540.01
+1.89%
Portage Biotech
BIOX12.670.18
+1.44%
Bioceres Crop Solutions Corp
TYL420.602.51
+0.60%
Tyler Technologies
TUSK3.63-0.10
-2.68%
Mammoth Energy Services

BIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIO has been closely correlated with BRKR. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then BRKR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIO
1D Price
Change %
BIO100%
+2.65%
BRKR - BIO
73%
Closely correlated
+1.58%
RVTY - BIO
71%
Closely correlated
+1.92%
MTD - BIO
56%
Loosely correlated
+1.58%
TMO - BIO
55%
Loosely correlated
+1.85%
DHR - BIO
52%
Loosely correlated
+0.23%
More